Patents Assigned to Omnigene, Inc.
  • Patent number: 5874278
    Abstract: A Bacillus cell contains a mutation in the epr gene resulting in inhibition of the production by the cell of the proteolytically active epr gene product; the cell may further contain mutations in the genes encoding proteolytically active residual protease I (RP-I) and proteolytically active residual protease II (RP-II) (mpr).
    Type: Grant
    Filed: April 15, 1997
    Date of Patent: February 23, 1999
    Assignee: OmniGene Inc.
    Inventors: Alan Sloma, Gerald A. Rufo, Jr., Cathy Faye Rudolph, Barbara J. Sullivan, Janice Pero
  • Patent number: 5620880
    Abstract: A Bacillus cell contains a mutation in the epr gene resulting in inhibition of the production by the cell of the proteolytically active epr gene product; the cell may further contain mutations in the genes encoding proteolytically active residual protease I (RP-I) and proteolytically active residual protease II (RP-II).
    Type: Grant
    Filed: September 7, 1990
    Date of Patent: April 15, 1997
    Assignee: Omnigene, Inc.
    Inventors: Alan Sloma, Gerald A. Rufo, Jr., Cathy F. Rudolph, Barbara J. Sullivan, Janice Pero
  • Patent number: 5589383
    Abstract: A Bacillus cell contains a mutation in the epr gene resulting in inhibition of the production by the cell of the proteolytically active epr gene product; the cell may further contain mutations in the genes encoding proteolytically active residual protease I (bpr) and proteolytically active residual protease II (RP-II).
    Type: Grant
    Filed: August 12, 1994
    Date of Patent: December 31, 1996
    Assignee: Omnigene, Inc.
    Inventors: Alan Sloma, Gerald A. Rufo, Jr., Cathy F. Rudolph, Barbara J. Sullivan, Janice Pero
  • Patent number: 5294542
    Abstract: A Bacillus cell containing a mutation in the residual protease III (rp-III) gene resulting in the inhibition of the production by the cell of proteolytically active RP-III.
    Type: Grant
    Filed: March 19, 1991
    Date of Patent: March 15, 1994
    Assignee: Omnigene, Inc.
    Inventors: Alan Sloma, Gerald A. Rufo, Jr., Janice Pero
  • Patent number: 5196350
    Abstract: An optical detection method for detecting specific ligands in an immunoassay is formed by diffracting a beam of light through slits formed in a mask and thererby forming an interference pattern. The diffracted light of one of the slits is distributed by an assay having a ligand which when reacted with anti-ligand changes the optical characteristics of the assay thereby changing the interference pattern in a concentration dependent manner.
    Type: Grant
    Filed: May 29, 1991
    Date of Patent: March 23, 1993
    Assignee: OmniGene, Inc.
    Inventors: Keith C. Backman, Christiane Munkholm
  • Patent number: 5188961
    Abstract: Engineered DNA encoding a pre-protein which comprises a Streptomyces chitinase signal sequence and a desired mature protein. Preferably, the signal sequence is from the S. plicatus endochitinase gene. The engineered DNA is included in a host organism causing the host to produce and secrete the mature protein. Where the mature protein is a chitinase, the invention is used in methods of controlling chitinase-sensitive pests.
    Type: Grant
    Filed: February 1, 1990
    Date of Patent: February 23, 1993
    Assignee: Omnigene, Inc.
    Inventors: Karen M. Overbye, Janice Pero, Phillips W. Robbins